Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has shared an update.
Recordati S.p.A. has updated its shareholders on the progress of its share buyback program, initiated on April 30, 2025. The program, which aims to purchase shares for stock option and performance share plans, saw the acquisition of 88,677 ordinary shares between May 12 and May 16, 2025, reflecting the company’s strategic focus on incentivizing management and aligning with future incentive plans.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy in the 1920s. The company provides therapeutic options in specialty drugs, general medicine, and rare diseases, with operations spanning clinical development to marketing across 150 countries in the EMEA, Americas, and APAC regions.
Average Trading Volume: 449,936
Technical Sentiment Signal: Buy
Current Market Cap: €10.62B
Find detailed analytics on REC stock on TipRanks’ Stock Analysis page.